Dopamine D3 receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: Role of hyperthermia

European Journal of Pharmacology

Volumn 732, Issue 1, 2014, Pages 105-110

  Baladi, Michelle G ^a   Newman, Amy H ^b   Nielsen, Shannon M ^a   Hanson, Glen R ^a   Fleckenstein, Annette E ^a  

^a UNIVERSITY OF UTAH   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Dopamine transporter; Methamphetamine; PG01037; Serotonin transporter

Indexed keywords

DOPAMINE; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE TRANSPORTER; METHAMPHETAMINE; N [4 [4 (2,3 DICHLOROPHENYL) PIPERAZIN 1 YL] TRANS BUT 2 ENYL] 4 PYRIDINE 2 YL BENZAMIDE; PG 01037; SEROTONIN; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG; CENTRAL STIMULANT AGENT; DOPAMINE RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG EFFECT; HYPERTHERMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; ANIMAL; DRUG EFFECTS; FEVER; HIPPOCAMPUS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SYNAPTOSOME; TOXICITY;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINERGIC NEURONS; FEVER; HIPPOCAMPUS; MALE; METHAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D3; SEROTONIN; SYNAPTOSOMES;

EID: 84921439084     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.03.023     Document Type: Article

References (52)

1. C. Achat-Mendes, D.M. Platt, and R.D. Spealman Antagonism of metabotropic glutamate 1 receptors attenuates behavioral effects of cocaine and methamphetamine in squirrel monkeys J. Pharmacol. Exp. Ther. 343 2012 214 224
2. D.S. Albers, and P.K. Sonsalla Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents J. Pharmacol. Exp. Ther. 275 1995 1104 1114 (Pubitemid 26129911)
3. M.G. Baladi, A.H. Newman, and C.P. France Dopamine D3 receptors mediate the discriminative stimulus effects of quinpirole in free-feeding rats J. Pharmacol. Exp. Ther. 332 2010 308 315
4. J.F. Bowyer, A.W. Tank, G.D. Newport, W. Slikker Jr., S.F. Ali, and R.R. Holson The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum J. Pharmacol. Exp. Ther. 260 1992 817 824
5. J.F. Bowyer, D.L. Davies, L. Schmued, H.W. Broening, G.D. Newport, W. Slikker Jr., and R.R. Holson Further studies of the role of hyperthermia in methamphetamine neurotoxicity J. Pharmacol. Exp. Ther. 268 1993 1571 1580
6. J.F. Bowyer, R.R. Holson, D.B. Miller, and J.P. O'Callaghan Phenobarbital and dizocilpine can block methamphetamine-induced neurotoxicity in mice by mechanisms that are independent of thermoregulation Brain Res. 919 2001 179 183 (Pubitemid 33016604)
7. H.W. Broening, L.L. Morford, and C.V. Vorhees Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions Synapse 56 2005 84 93 (Pubitemid 40389559)
8. F. Chaperon, M.D. Tricklebank, L. Unger, and H.C. Neijt Evidence for regulation of body temperature in rats by dopamine D2 receptor and possible influence of D1 but not D3 and D4 receptors Neuropharmacology 44 2003 1047 1053 (Pubitemid 36570429)
9. D.S. Chapin, K.J. Lookingland, and K.E. Moore Effects of LC mobile phase composition on retention times for biogenic amines, and their precursors and metabolites Curr. Sep. 7 1986 68 71
10. G.T. Collins, J.M. Witkin, A.H. Newman, K.A. Svensson, P. Grundt, J. Cao, and J.H. Woods Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior J. Pharmacol. Exp. Ther. 314 2005 310 319 (Pubitemid 41058268)
11. G.T. Collins, A.H. Newman, P. Grundt, K.C. Rice, S.M. Husbands, C. Chauvignac, J. Chen, S. Wang, and J.H. Woods Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists Psychopharmacology 193 2007 159 170 (Pubitemid 47025018)
12. A.J. Eisch, S.J. O'Dell, and J.F. Marshall Striatal and cortical NMDA receptors are altered by a neurotoxic regimen of methamphetamine Synapse 22 1996 217 225 (Pubitemid 26066440)
13. G.M. Farfel, and L.S. Seiden Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan J. Pharmacol. Exp. Ther. 272 1995 868 875
14. A.E. Fleckenstein, R.R. Metzger, D.G. Wilkins, J.W. Gibb, and G.R. Hanson Rapid and reversible effects of methamphetamine on dopamine transporters J. Pharmacol. Exp. Ther. 282 1997 834 838 (Pubitemid 27340185)
15. N. Granado, S. Ares-Santos, I. Oliva, E. O'Shea, E.D. Martin, M.I. Colado, and R. Moratalla Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA Neurobiol. Dis. 42 2011 391 403
16. N.B. Gross, P.C. Duncker, and J.F. Marshall Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity Synapse 65 2011 1144 1155
17. P. Grundt, E.E. Carlson, J. Cao, C.J. Bennett, E. McElveen, M. Taylor, R.R. Luedtke, and A.H. Newman Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor J. Med. Chem. 48 2005 839 848 (Pubitemid 40209106)
18. G.C. Hadlock, P.W. Chu, E.T. Walters, G.R. Hanson, and A.E. Fleckenstein Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation J. Pharmacol. Exp. Ther. 335 2010 207 212
19. G.C. Hadlock, K.M. Webb, L.M. McFadden, P.W. Chu, J.D. Ellis, S.C. Allen, D.M. Andrenyak, P.L. Vieira-Brock, C.L. German, K.M. Conrad, A.J. Hoonakker, J.W. Gibb, D.G. Wilkins, G.R. Hanson, and A.E. Fleckenstein 4- Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse J. Pharmacol. Exp. Ther. 339 2011 530 536
20. H.M. Haughey, A.E. Fleckenstein, R.R. Metzger, and G.R. Hanson The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia J. Neurochem. 75 2000 1608 1617
21. C.A. Heidbreder, E.L. Gardner, Z.X. Xi, P.K. Thanos, M. Mugnaini, J.J. Hagan, and C.R. Ashby Jr. The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence Brain Res. Rev. 49 2005 77 105 (Pubitemid 40800164)
22. A.E. Higley, K. Spiller, P. Grundt, A.H. Newman, S.W. Kiefer, Z.X. Xi, and E.L. Gardner PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats J. Psychopharmacol. 25 2011 263 273
23. C.D. Howard, K.A. Keefe, P.A. Garris, and D.P. Daberkow Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum J. Neurochem. 118 2011 668 676
24. K.M. Kahlig, F. Binda, H. Khoshbouei, R.D. Blakely, D.G. McMahon, J.A. Javitch, and A. Galli Amphetamine induces dopamine efflux through a dopamine transporter channel Proc. Nat. Acad. Sci. U.S.A. 102 2005 3495 3500 (Pubitemid 40328073)
25. E.A. Kiyatkin The hidden side of drug action: brain temperature changes induced by neuroactive drugs Psychopharmacology 225 2013 765 780
26. W. Koek, L.P. Carter, H. Wu, A. Coop, and C.P. France Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with γ-hydroxybutyrate and its precursors 1,4-butanediol and γ-butyrolactone Behav. Pharmacol. 17 2006 239 247
27. F.J. Kogan, W.K. Nichols, and J.W. Gibb Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels Eur. J. Pharmacol. 36 1976 363 371
28. G.F. Koob, and N.D. Volkow Neurocircuitry of addiction Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 35 2010 217 238
29. R. Kuczenski, D.S. Segal, A.K. Cho, and W. Melega Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine J. Neurosci. 15 1995 1308 1317
30. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
31. U.D. McCann, D.F. Wong, F. Yokoi, V. Villemagne, R.F. Dannals, and G.A. Ricaurte Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428 J. Neurosci.: The Official Journal of the Society for Neuroscience 18 1998 8417 8422 (Pubitemid 28465016)
32. L.M. McFadden, G.C. Hadlock, S.C. Allen, P.L. Vieira-Brock, K.A. Stout, J.D. Ellis, A.J. Hoonakker, D.M. Andrenyak, S.M. Nielsen, D.G. Wilkins, G.R. Hanson, and A.E. Fleckenstein Methampheatmine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure J. Pharmacol. Exp. Ther. 340 2011 295 303
33. B.A. McGuire, M.G. Baladi, and C.P. France Eating high-fat chow enhances sensitization to the effects of methamphetamine on locomotion in rats Eur. J. Pharmacol. 658 2011 156 159
34. W.P. Melega, M.J. Raleigh, D.B. Stout, G. Lacan, S.C. Huang, and M.E. Phelps Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey Brain Res. 766 1997 113 120 (Pubitemid 27431441)
35. R.R. Metzger, H.M. Haughey, D.G. Wilkins, J.W. Gibb, G.R. Hanson, and A.E. Fleckenstein Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia J. Pharmacol. Exp. Ther. 295 2000 1077 1085
36. P. Munzar, M.H. Baumann, M. Shoaib, and S.R. Goldberg Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats Psychopharmacology 141 1999 287 296 (Pubitemid 29196078)
37. B.J. Myles, L.A. Jarrett, S.L. Broom, H. Anton Speaker, and K.E. Sabol The effects of methamphetamine on core body temperature in the rat- Part I: Chronic treatment and ambient temperature Psychopharmacology 198 2008 301 311
38. M. Nakayama, T. Koyama, and I. Yamashita Long-lasting decrease in dopamine uptake sites following repeated administration of methamphetamine in the rat striatum Brain Res. 601 1993 209 212 (Pubitemid 23047683)
39. A.H. Newman, P. Grundt, and M.A. Nader Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents J. Med. Chem. 48 2005 3663 3679 (Pubitemid 40776839)
40. S.J. O'Dell, F.B. Weihmuller, and J.F. Marshall Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity Brain Res. 564 1991 256 260
41. S.J. O'Dell, F.B. Weihmuller, and J.F. Marshall Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists J. Neurochem. 60 1993 1792 1799 (Pubitemid 23127585)
42. M. Raiteri, F. Cerrito, A.M. Cervoni, and G. Levi Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine J. Pharmacol. Exp. Ther. 208 1979 195 202 (Pubitemid 9191708)
43. K.E. Sabol, D.M. Yancey, H. Anton Speaker, and S.L. Mitchell Methampheatmine and core temperature in the rat: ambient temperature, dose, and the effect of a D2 receptor blocker Psychopharmcology 228 2013 551 561
44. C.J. Schmidt, C.K. Black, G.M. Abbate, and V.L. Taylor Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors Brain Res. 529 1990 85 90 (Pubitemid 20326842)
45. L.S. Seiden, M.W. Fischman, and C.R. Schuster Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys Drug Alcohol depend. 1 1976 215 219
46. Y. Sekine, M. Iyo, Y. Ouchi, T. Matsunaga, H. Tsukada, H. Okada, E. Yoshikawa, M. Futatsubashi, N. Takei, and N. Mori Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET Am. J. Psychiatry 158 2001 1206 1214 (Pubitemid 32717692)
47. P.K. Sonsalla, J.W. Gibb, and G.R. Hanson Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems J. Pharmacol. Exp. Ther. 238 1986 932 937 (Pubitemid 16033231)
48. S.E. Stephans, and B.K. Yamamoto Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux Synapse 17 1994 203 209 (Pubitemid 24204347)
49. D.A. Tata, and B.K. Yamamoto Chronic stress enhances methamphetamine- induced extraceullar glutamate and excitotoxicity in the rat striatum Synapse 62 2008 325 336 (Pubitemid 351451800)
50. N.D. Volkow, L. Chang, G.J. Wang, J.S. Fowler, M. Leonido-Yee, D. Franceschi, M.J. Sedler, S.J. Gatley, R. Hitzemann, Y.S. Ding, J. Logan, C. Wong, and E.N. Miller Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers Am. J. Psychiatry 158 2001 377 382 (Pubitemid 32205193)
51. G.C. Wagner, G.A. Ricaurte, L.S. Seiden, C.R. Schuster, R.J. Miller, and J. Westley Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine Brain Res. 181 1980 151 160 (Pubitemid 10159505)
52. J.M. Wilson, K.S. Kalasinsky, A.I. Levey, C. Bergeron, G. Reiber, R.M. Anthony, G.A. Schmunk, K. Shannak, J.W. Haycock, and S.J. Kish Striatal dopamine nerve terminal markers in human, chronic methamphetamine users Nat. Med. 2 1996 699 703 (Pubitemid 26191961)